At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ECOR Electrocore LLC
Market Closed 03-27 16:00:00 EDT
5.86
-0.16
-2.66%
盘后5.86
+0.000.00%
16:10 EDT
High6.32Low5.77Vol58.70K
Open6.03D1 Closing6.02Amplitude9.13%
Mkt Cap47.37MTradable Cap30.02MTotal Shares8.08M
T/O352.30KT/O Rate1.15%Tradable Shares5.12M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Electrocore’s gammaCore Pipeline Faces Material Trial Disruption Risks From Regulatory, Enrollment and Operational Challenges
TIPRANKS  ·  03-21
Electrocore’s gammaCore Pipeline Faces Material Trial Disruption Risks From Regulatory, Enrollment and Operational Challenges
Analysts Offer Insights on Healthcare Companies: Electrocore (ECOR) and Regeneron (REGN)
TIPRANKS  ·  03-20
Analysts Offer Insights on Healthcare Companies: Electrocore (ECOR) and Regeneron (REGN)
Corrected-electroCore: FY 2025 Loss per Share $1.65 (Not 'EPS $1.65')
THOMSON REUTERS  ·  03-20
Corrected-electroCore: FY 2025 Loss per Share $1.65 (Not 'EPS $1.65')
ElectroCore CEO Goldberger to Retire
Dow Jones  ·  03-20
ElectroCore CEO Goldberger to Retire
BRIEF-Electrocore Announces Full Year 2025 Financial Results And Organizational Changes
Reuters  ·  03-20
BRIEF-Electrocore Announces Full Year 2025 Financial Results And Organizational Changes
electroCore Q4 EPS $(0.34) Beats $(0.41) Estimate, Sales $9.200M Beat $9.039M Estimate
Benzinga  ·  03-20
electroCore Q4 EPS $(0.34) Beats $(0.41) Estimate, Sales $9.200M Beat $9.039M Estimate
electroCore FY2025 net sales rise 27% to USD 32.03 million as GAAP net loss widens to USD 13.97 million
Reuters  ·  03-20
electroCore FY2025 net sales rise 27% to USD 32.03 million as GAAP net loss widens to USD 13.97 million
electroCore: FY2025 Revenue $32 Mln
THOMSON REUTERS  ·  03-20
electroCore: FY2025 Revenue $32 Mln
electroCore: for FY 2026, Co Providing Revenue Guidance of About 30% Annual REV Growth Over 2025
THOMSON REUTERS  ·  03-20
electroCore: for FY 2026, Co Providing Revenue Guidance of About 30% Annual REV Growth Over 2025
electroCore, Inc. - Dan Goldberger to Retire as CEO Effective April 1, 2026; Joshua Lev Named Interim President and CFO
THOMSON REUTERS  ·  03-20
electroCore, Inc. - Dan Goldberger to Retire as CEO Effective April 1, 2026; Joshua Lev Named Interim President and CFO
electroCore: FY 2025 EPS $1.65
THOMSON REUTERS  ·  03-20
electroCore: FY 2025 EPS $1.65
Press Release: electroCore Announces Full Year 2025 Financial Results and Organizational Changes
Dow Jones  ·  03-20
Press Release: electroCore Announces Full Year 2025 Financial Results and Organizational Changes
RBC Capital Sticks to Its Buy Rating for Ecora Royalties PLC (ECOR)
TIPRANKS  ·  03-18
RBC Capital Sticks to Its Buy Rating for Ecora Royalties PLC (ECOR)
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  03-18
Calendar of U.S. Earnings Expected in the Week Ahead
electroCore, Inc. expected to post a loss of 41 cents a share - Earnings Preview
Reuters  ·  03-18
electroCore, Inc. expected to post a loss of 41 cents a share - Earnings Preview
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  03-16
Calendar of U.S. Earnings Expected in the Week Ahead
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  03-13
Calendar of U.S. Earnings Expected in the Week Ahead
RBC Capital Keeps Their Buy Rating on Ecora Royalties PLC (ECOR)
TIPRANKS  ·  03-13
RBC Capital Keeps Their Buy Rating on Ecora Royalties PLC (ECOR)
electroCore management to participate in the 38th Annual Roth Conference
Reuters  ·  03-10
electroCore management to participate in the 38th Annual Roth Conference
electroCore, Inc. expected to post a loss of 41 cents a share - Earnings Preview
Reuters  ·  03-07
electroCore, Inc. expected to post a loss of 41 cents a share - Earnings Preview

Introduction

Company Name.
Electrocore LLC
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Issue price:
--